 clinic benefit structur function chang calcium antagonist calcium antagonist larg varieti pharmacolog effect addit drug manag hypertens calcium antagonist scrutini possibl benefici advers effect circul risk factor profil concern rel resist coronari heart diseas antihypertens drug treatment interest impact blood pressure-low drug surrog endpoint left ventricular hypertrophi pharmacokinet pharmacodynam heterogen calcium antagonist wise mind subtyp prototyp nifedipin diltiazem verapamil type great caution increas understand divers calcium antagonist pathophysiolog hypertens vascular diseas excit futur calcium antagonist cardiovascular therapeut